Avid Bioservices Inc
Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stabilit… Read more
Market Cap & Net Worth: Avid Bioservices Inc (CDMO)
Avid Bioservices Inc (NASDAQ:CDMO) has a market capitalization of $798.90 Million ($798.90 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #9137 globally and #4459 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Avid Bioservices Inc's stock price $12.49 by its total outstanding shares 63963300 (63.96 Million).
Avid Bioservices Inc Market Cap History: 2015 to 2025
Avid Bioservices Inc's market capitalization history from 2015 to 2025. Data shows growth from $395.15 Million to $798.90 Million (9.01% CAGR).
Avid Bioservices Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Avid Bioservices Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.65x
Avid Bioservices Inc's market cap is 5.65 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $395.15 Million | $26.78 Million | -$50.36 Million | 14.75x | N/A |
| 2016 | $104.16 Million | $44.69 Million | -$55.65 Million | 2.33x | N/A |
| 2017 | $187.20 Million | $57.63 Million | -$28.16 Million | 3.25x | N/A |
| 2018 | $262.25 Million | $53.62 Million | -$21.81 Million | 4.89x | N/A |
| 2019 | $490.60 Million | $53.60 Million | -$4.21 Million | 9.15x | N/A |
| 2020 | $738.14 Million | $59.70 Million | -$7.26 Million | 12.36x | N/A |
| 2021 | $1.87 Billion | $95.87 Million | $11.21 Million | 19.47x | 166.47x |
| 2022 | $880.77 Million | $119.60 Million | $127.67 Million | 7.36x | 6.90x |
| 2023 | $415.76 Million | $149.27 Million | $560.00K | 2.79x | 742.43x |
| 2024 | $789.95 Million | $139.91 Million | -$140.75 Million | 5.65x | N/A |
Competitor Companies of CDMO by Market Capitalization
Companies near Avid Bioservices Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Avid Bioservices Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Avid Bioservices Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Avid Bioservices Inc's market cap moved from $395.15 Million to $ 798.90 Million, with a yearly change of 9.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $798.90 Million | +1.13% |
| 2024 | $789.95 Million | +90.00% |
| 2023 | $415.76 Million | -52.80% |
| 2022 | $880.77 Million | -52.81% |
| 2021 | $1.87 Billion | +152.86% |
| 2020 | $738.14 Million | +50.46% |
| 2019 | $490.60 Million | +87.07% |
| 2018 | $262.25 Million | +40.09% |
| 2017 | $187.20 Million | +79.73% |
| 2016 | $104.16 Million | -73.64% |
| 2015 | $395.15 Million | -- |
End of Day Market Cap According to Different Sources
On Feb 3rd, 2026 the market cap of Avid Bioservices Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $798.90 Million USD |
| MoneyControl | $798.90 Million USD |
| MarketWatch | $798.90 Million USD |
| marketcap.company | $798.90 Million USD |
| Reuters | $798.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.